Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' SCHUTTE J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 38 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wang, L; Darling, J; Zhang, JS; Liu, WG; Qian, JQ; Bostwick, D; Hartmann, L; Jenkins, R; Bardenhauer, W; Schutte, J; Opalka, B; Smith, DI
      Loss of expression of the DRR I gene at chromosomal segment 3p21.1 in renal cell carcinoma

      GENES CHROMOSOMES & CANCER
    2. Ren, SR; Smith, MJ; Louro, ID; McKie-Bell, P; Bani, MR; Wagner, M; Zochodne, B; Redden, DT; Grizzle, WE; Wang, ND; Smith, DI; Herbst, RA; Bardenheuer, W; Opalka, B; Schutte, J; Trent, JM; Ben-David, Y; Ruppert, JM
      The p44(S10) locus, encoding a subunit of the proteasome regulatory particle, is amplified during progression of cutaneous malignant melanoma

      ONCOGENE
    3. Flasshove, M; Meusers, P; Schutte, J; Noppeney, R; Beelen, DW; Sohrab, S; Roggenbuck, U; Kemmeries, G; Brittinger, G; Seeber, S; Scheulen, ME
      Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia

      ANNALS OF HEMATOLOGY
    4. Schroder, JK; Kolkenbrock, S; Tins, J; Kasimir-Bauer, S; Seeber, S; Schutte, J
      Analysis of thrombopoietin receptor (c-mpl) mRNA expression in de novo acute myeloid leukemia

      LEUKEMIA RESEARCH
    5. Werner, NS; Siprashvili, Z; Fong, LYY; Marquitan, G; Schroder, JK; Bardenheuer, W; Seeber, S; Huebner, K; Schutte, J; Opalka, B
      Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression

      CANCER RESEARCH
    6. Brocker, F; Bardenheuer, W; Vieten, L; Julicher, K; Werner, N; Marquitan, G; Michael, D; Opalka, B; Schutte, J
      Assignment of human filamin gene FLNB to human chromosome band 3p14.3 and identification of YACs containing the complete FLNB transcribed region

      CYTOGENETICS AND CELL GENETICS
    7. Flasshove, M; Frings, W; Schroder, JK; Moritz, T; Schutte, J; Seeber, S
      Transfer of the cytidine deaminase cDNA into hematopoietic cells

      LEUKEMIA RESEARCH
    8. Eberhardt, W; Stamatis, G; Stuschke, M; Wilke, H; Muller, MR; Kolks, S; Flasshove, M; Schutte, J; Stahl, M; Schlenger, L; Budach, V; Greschuchna, D; Stuben, G; Teschler, H; Sack, H; Seeber, S
      Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial

      BRITISH JOURNAL OF CANCER
    9. Julicher, K; Marquitan, G; Werner, N; Bardenheuer, W; Vieten, L; Brocker, F; Topal, H; Seeber, S; Opalka, B; Schutte, J
      Novel tumor suppressor locus in human chromosome region 3p14.2

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    10. VIETEN L; BELAIR CD; SAVELIEVA L; JULICHER K; BROCKER F; BARDENHEUER W; SCHUTTE J; OPALKA B; REZNIKOFF CA
      MINIMAL DELETION OF 3P13-]14.2 ASSOCIATED WITH IMMORTALIZATION OF HUMAN UROEPITHELIAL CELLS

      Genes, chromosomes & cancer
    11. NOWROUSIAN MR; WELT A; FOSSA A; KASPER C; SCHRODER J; KUHLMANN S; SCHUTTE J; KLOKE O; STUSCHKE M; SCHULEHEIN K; METZ KA; LEDER LD; SACK H; SEEBER S
      RESPONSE-ADAPTED SEQUENTIAL COMBINATION CHEMOTHERAPY (CEBOPP VIML) FOLLOWED BY RADIOTHERAPY FOR BULKY AND ADVANCED-STAGE HODGKINS-DISEASE/

      Annals of oncology
    12. Hense, J; Kolkenbrock, S; Schutte, J
      Merkel cell carcinoma: Case reports and review of the literature

      TUMORDIAGNOSTIK & THERAPIE
    13. KIRCH HC; SCHRODER J; HOPPE H; ESCHE H; SEEBER S; SCHUTTE J
      RECOMBINANT GENE-PRODUCTS OF 2 NATURAL VARIANTS OF THE HUMAN CYTIDINEDEAMINASE GENE CONFER DIFFERENT DEAMINATION RATES OF CYTARABINE IN-VITRO

      Experimental hematology
    14. MAHLATI P; MLISANA Z; MANDELL B; SCHUTTE J; MJI D; MKHIZE Z
      MESSAGES AT THE LAUNCH OF THE SA-MEDICAL-ASSOCIATION

      South African medical journal
    15. SCHRODER JK; SEIDELMANN M; KIRCH HC; SEEBER S; SCHUTTE J
      ASSESSMENT OF RESISTANCE INDUCTION TO CYTOSINE-ARABINOSIDE FOLLOWING TRANSFER AND OVEREXPRESSION OF THE DEOXYCYTIDYLATE DEAMINASE GENE IN-VITRO

      Leukemia research
    16. WELT A; ANHUF J; KRAWCZYK C; FOSSA A; STUSCHKE M; KLOKE O; SCHUTTE J; WESTERHAUSEN M; SACK H; SEEBER S; NOWROUSIAN MR
      INITIAL HIGH-DOSE SEQUENTIAL CHEMOTHERAPY IN THE TREATMENT OF AGGRESSIVE NON-HODGKIN LYMPHOMAS WITH RISK-FACTORS

      British Journal of Haematology
    17. Schroder, JK; Kirch, C; Seeber, S; Schutte, J
      Structural and functional analysis of the cytidine deaminase gene in patients with acute myeloid leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    18. HARSTRICK A; FOSSA A; ZASADZINSKI E; MAYER S; BOJKO P; FLASSHOVE M; NOWROUSIAN MR; SCHUTTE J; SEEBER S
      INTENSIFIED SALVAGE THERAPY FOR GERM-CELL CANCER USING SEQUENTIAL CYCLES OF HIGH-DOSE CARBOPLATIN ETOPOSIDELCYDO-PHOSPHAMIDE (CEC)/

      European journal of cancer
    19. JULICHER K; VIETEN L; BROCKER F; BARDENHEUER W; SCHUTTE J; OPALKA B
      YEAST ARTIFICIAL CHROMOSOME TRANSFER INTO HUMAN RENAL-CARCINOMA CELLSBY SPHEROPLAST FUSION

      Genomics
    20. TRARBACH T; SCHEULEN ME; SCHRODER J; STUSCHKE M; SEEBER S; SCHUTTE J
      PHASE-II TRIAL OF FIRST-LINE HIGH-DOSE IFOSFAMIDE IN ADVANCED ADULT SOFT-TISSUE SARCOMA

      Tumordiagnostik & Therapie
    21. LUX A; BARDENHEUER W; MICHAEL D; BROCKER F; JULICHER K; VIETEN L; MICHAELIS S; SEEBER S; OPALKA B; SCHUTTE J
      IDENTIFICATION OF NOVEL EXPRESSED SEQUENCE TAGS WITHIN THE FHIT GENE LOCUS IN HUMAN-CHROMOSOME REGION 3P14.2

      Human genetics
    22. SCHUTTE J
      MEDICAL-ETHICS AND LEGAL AFFAIRS

      South African medical journal
    23. BARDENHEUER W; MICHAELIS S; LUX A; VIETEN L; BROCKER F; JULICHER K; WILLERS C; SIEBERT R; SMITH DI; VANDERHOUT AH; BUYS C; SCHUTTE J; OPALKA B
      CONSTRUCTION OF A CONSISTENT YAC CONTIG FOR HUMAN-CHROMOSOME REGION 3P14.1

      PCR methods and applications
    24. SCHRODER JK; KIRCH C; FLASSHOVE M; KALWEIT H; SEIDELMANN M; HILGER R; SEEBER S; SCHUTTE J
      CONSTITUTIVE OVEREXPRESSION OF THE CYTIDINE DEAMINASE GENE CONFERS RESISTANCE TO CYTOSINE-ARABINOSIDE IN-VITRO

      Leukemia
    25. SCHUTTE J
      MEDICAL-ETHICS AND LEGAL AFFAIRS

      South African medical journal
    26. WILLERS CP; SIEBERT R; BARDENHEUER W; LUX A; MICHAELIS S; SEEBER S; LUBOLDT HJ; OPALKA B; SCHUTTE J
      GENETIC INSTABILITY OF 3P12-P21-SPECIFIC MICROSATELLITE SEQUENCES IN RENAL-CELL CARCINOMA

      British Journal of Urology
    27. FLASSHOVE M; MORITZ T; SCHRODER J; SEEBER S; SCHUTTE J
      TRANSFER OF CYTIDINE DEAMINASE (CDD) INTO HEMATOPOIETIC-CELLS INCREASES RESISTANCE TO CYTARABINE (ARA-C)

      Blood
    28. PARADEE W; MULLINS C; HE ZQ; GLOVER T; WILKE C; OPALKA B; SCHUTTE J; SMITH DI
      PRECISE LOCALIZATION OF APHIDICOLIN-INDUCED BREAKPOINTS ON THE SHORT ARM OF HUMAN-CHROMOSOME-3

      Genomics
    29. KRISMANN M; TODT B; SCHRODER J; GAREIS D; MULLER KM; SEEBER S; SCHUTTE J
      LOW SPECIFICITY OF CYTOKERATIN 19 REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION ANALYSES FOR DETECTION OF HEMATOGENOUS LUNG-CANCER DISSEMINATION

      Journal of clinical oncology
    30. LUX A; BARDENHEUER W; SZYMANSKI S; SIEBERT R; WILLERS C; GOCKEL A; SCHRAMM A; STROTHE M; SMITH D; WANG ND; HEPPELPARTON AC; VANDERHOUT A; VANDERBERG A; OPALKA B; SCHUTTE J
      CONSTRUCTION OF A 3P14 YAC CONTIG WITH MICRODISSECTION CLONES FROM A 3P14-SPECIFIC MICRODISSECTION LIBRARY

      Cytogenetics and cell genetics
    31. MICHAELIS SC; BARDENHEUER W; LUX A; SCHRAMM A; GOCKEL A; SIEBERT R; WILLERS C; SCHMIDTKE K; TODT B; VANDERHOUT AH; BUYS CHCM; HEPPELLPARTON AC; RABBITTS PH; UNGAR S; SMITH D; LEPASLIER D; COHEN D; OPALKA B; SCHUTTE J
      CHARACTERIZATION AND CHROMOSOMAL ASSIGNMENT OF YEAST ARTIFICIAL CHROMOSOMES CONTAINING HUMAN 3P13-P21-SPECIFIC SEQUENCE-TAGGED SITES

      Cancer genetics and cytogenetics
    32. KNAUF WU; HILGENFELD E; SCHUTTE J; KREUSER ED; KATH R; BERDEL WE; THIEL E
      HIGH EFFECTIVENESS OF 2-CDA IN B-CELL LEUKEMIC LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL), BUT CONSIDERABLE RISK FOR INFECTION

      Blood
    33. BARDENHEUER W; SZYMANSKI S; LUX A; LUDECKE HJ; HORSTHEMKE B; CLAUSSEN U; SENGER G; SMITH DI; WANG ND; LEPASLIER D; COHEN D; HEPPELLPARTON A; RABBITTS P; SCHUTTE J; OPALKA B
      CHARACTERIZATION OF A MICRODISSECTION LIBRARY FROM HUMAN-CHROMOSOME REGION 3P14

      Genomics
    34. FLASSHOVE M; STRUMBERG D; AYSCUE L; MITCHELL BS; TIRIER C; HEIT W; SEEBER S; SCHUTTE J
      STRUCTURAL-ANALYSIS OF THE DEOXYCYTIDINE KINASE GENE IN PATIENTS WITHACUTE MYELOID-LEUKEMIA AND RESISTANCE TO CYTOSINE-ARABINOSIDE

      Leukemia
    35. CHRISTENSEN B; ANNWEILER H; SCHUTTE J; SCHINDLER AE
      MALIGNANT MIXED MULLERIAN TUMORS - PROGNO SIS, DEVELOPMENT, AND CHEMOTHERAPEUTICAL POSSIBILITIES IN ADVANCED OR RECURRENT TUMORS

      Tumordiagnostik & Therapie
    36. BARDENHEUER W; SZYMANSKI S; LUX A; HORSTHEMKE B; CLAUSSEN U; SMITH D; WANG ND; SCHUTTE J; OPALKA B
      CHARACTERIZATION OF A HUMAN CHROMOSOME-3P14-SPECIFIC MICRODISSECTION LIBRARY

      Cytogenetics and cell genetics
    37. SZYMANSKI SC; BARDENHEUER W; LUX A; HORSTHEMKE H; CLAUSSEN U; SMITH D; WANG ND; LEPALSIER D; HEPPELLPARTON AC; OPALKA B; SCHUTTE J
      MAPPING AND CHARACTERIZATION OF YACS ISOLATED BY P14-SPECIFIC MICRODISSECTION CLONES

      Cytogenetics and cell genetics
    38. SCHUTTE J; OPALKA B; BECHER R; BARDENHEUER W; SZYMANSKI S; LUX A; SEEBER S
      ANALYSIS OF THE P53 GENE IN PATIENTS WITH ISOCHROMOSOME-17Q AND PH(1)-POSITIVE OR PH1-NEGATIVE MYELOID-LEUKEMIA

      Leukemia research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/11/20 alle ore 02:27:30